Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
| Revenue (Most Recent Fiscal Year) | $40.11B |
| Net Income (Most Recent Fiscal Year) | $5.72B |
| PE Ratio (Current Year Earnings Estimate) | 22.64 |
| PE Ratio (Trailing 12 Months) | 23.83 |
| PEG Ratio (Long Term Growth Estimate) | 2.52 |
| Price to Sales Ratio (Trailing 12 Months) | 4.51 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 4.66 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 16.44 |
| Pre-Tax Margin (Trailing 12 Months) | 16.21% |
| Net Margin (Trailing 12 Months) | 13.96% |
| Return on Equity (Trailing 12 Months) | 20.18% |
| Return on Assets (Trailing 12 Months) | 10.60% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.60 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.11 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.32 |
| Inventory Turnover (Trailing 12 Months) | 2.69 |
| Book Value per Share (Most Recent Fiscal Quarter) | $22.44 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.98 |
| Earnings per Share (Most Recent Fiscal Year) | $4.44 |
| Diluted Earnings per Share (Trailing 12 Months) | $3.21 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 1.74B |
| Free Float | 1.72B |
| Market Capitalization | $181.95B |
| Average Volume (Last 20 Days) | 5.30M |
| Beta (Past 60 Months) | 0.76 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.10% |
| Percentage Held By Institutions (Latest 13F Reports) | 75.18% |
| Annual Dividend (Based on Last Quarter) | $2.20 |
| Dividend Yield (Based on Last Quarter) | 2.10% |